Promising growth and investment in the cell therapy industry during the first quarter of 2012
- PMID: 22560072
- DOI: 10.1016/j.stem.2012.04.018
Promising growth and investment in the cell therapy industry during the first quarter of 2012
Abstract
In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.
Copyright © 2012 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
